Laser showdown: where to zap the iris for better glaucoma control?

NCT ID NCT07195370

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two different spots (temporal vs inferior) for a YAG laser iridotomy in people with angle-closure glaucoma. Each patient gets one spot in each eye, and doctors track pressure, symptoms, and complications over six months. The goal is to find which location is safer and more effective at lowering eye pressure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
YAG laser peripheral iridotomy (a procedure using a laser to create a small hole in the iris to improve fluid drainage)
What this could lead to
If successful, this could identify the best location for the laser procedure, potentially reducing complications and improving pressure control in glaucoma patients.
What could go wrong
This is a small, early-stage study with only 150 participants, and results may not apply to all patients. The procedure itself carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGLE-CLOSURE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Isfahan University of Medical Sciences

    Isfahan, Isfahan, 0098, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.